Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-To-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
media
posted on 2021-12-06, 16:23 authored by Adis journals on behalf of:, April Armstrong, Andrew Blauvelt, Eric L. Simpson, Catherine H. Smith, Pedro Herranz, Yoko Kataoka, Seo Seong-Jun, Silvia M. Ferrucci, Jingdong Chao, Zhen Chen, Ana B. Rossi, Brad Shumel, Paul Tomondy<p>The above video represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2021.</p>
<p> </p>
